DSCGX
Price
$29.18
Change
+$0.24 (+0.83%)
Updated
Dec 24 closing price
VEXRX
Price
$115.76
Change
+$0.90 (+0.78%)
Updated
Dec 24 closing price
Ad is loading...

DSCGX vs VEXRX

Header iconDSCGX vs VEXRX Comparison
Open Charts DSCGX vs VEXRXBanner chart's image
DFA US Small Cap Growth Instl
Price$29.18
Change+$0.24 (+0.83%)
VolumeN/A
CapitalizationN/A
Vanguard Explorer Adm
Price$115.76
Change+$0.90 (+0.78%)
VolumeN/A
CapitalizationN/A
DSCGX vs VEXRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DSCGX vs. VEXRX commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSCGX is a Hold and VEXRX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 23.9B vs. DSCGX (1.44B). DSCGX pays higher dividends than VEXRX: DSCGX (0.66) vs VEXRX (0.58). DSCGX was incepted earlier than VEXRX: DSCGX (12 years) vs VEXRX (23 years). VEXRX is a more actively managed with annual turnover of: 40.00 vs. DSCGX (25.00). DSCGX has a lower initial minimum investment than VEXRX: DSCGX (0) vs VEXRX (50000). DSCGX annual gain was more profitable for investors over the last year : 14.08 vs. VEXRX (12.31). DSCGX return over 5 years is better than : 51.78 vs. VEXRX (18.28).
DSCGXVEXRXDSCGX / VEXRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years23 years-
Gain YTD14.52912.138120%
Front LoadN/AN/A-
Min. Initial Investment050000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.44B23.9B6%
Annual Yield % from dividends0.660.58114%
Returns for 1 year14.0812.31114%
Returns for 3 years11.45-2.10-546%
Returns for 5 years51.7818.28283%
Returns for 10 years101.2832.48312%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMRC22.850.50
+2.24%
Ameresco
VEEV224.890.74
+0.33%
Veeva Systems
FIVN42.48-0.15
-0.35%
Five9
BRDG8.46-0.04
-0.47%
Bridge Investment Group Holdings
OTLK1.42-0.02
-1.39%
Outlook Therapeutics